BEUDAMED
    FDA Adverse Event Injury Summary report: N

    SILEX SACROILIAC JOINT FUSION SYSTEM

    MDR report key: 12236196 · Received July 28, 2021

    Report

    Report Number
    3005031160-2021-00014
    Event Type
    Injury
    Date Received
    July 28, 2021
    Date of Event
    June 23, 2021
    Report Date
    August 25, 2021
    Manufacturer
    XTANT MEDICAL
    Product Code
    OUR
    PMA / PMN Number
    K140079
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    TX, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL

    Narratives

    Description of Event or Problem · 0

    ON (B)(6) 2021 A CONFERENCE CALL WITH THE COMPLAINANT, MANUFACTURER PRODUCT MANAGER, AND REGULATORY AFFAIRS ASSOCIATE WAS MADE TO DISCUSS PATIENT STATUS, TECHNIQUES FOR A SUCCESSFULL REMOVAL/REVISION, AND SCHEDULING OF THE ADDITIONAL SURGICAL PROCEDURE. AN ADDITIONAL PHYSICIAN WAS CONSULTED ON THE CASE AND HAS A PLAN FOR SUCCESSFUL REMOVAL/REVISION OF THE DEVICE. THE COMPLAINANT DID NOT KNOW WHEN THE REMOVAL PREOCEDURE WOULD BE SCHEDULED AND INDICATED THAT ELECTIVE SURGERIES IN THEIR AREA HAVE BEEN PUT ON HOLD DUE TO THE COVID-19 PANDEMIC. THE PATIENT IS IN GOOD HEALTH STATUS, IT IS UNKNOWN WHEN THE REVISION SURGERY WILL OCCUR. THE MANUFACTURER IS SUBMITTING THIS FOLLOW-UP MDR. THIS FOLLOW-UP REPORT IS ASSOCIATED WITH MFR 3005031160-2021-00014.

    Additional Manufacturer Narrative · 1

    A DHR REVIEW COULD NOT BE PERFORMED DUE TO THE DEVICE PART AND LOT NUMBER NOT BEING AVAILABLE. A PHONE CALL WITH THE VP OF MARKETING, DIRECTOR OF HARDWARE ENGINEERING, AND THE MARKETING PRODUCT MANAGER WAS MADE ON 6/30/2021 TO DISCUSS THE SYSTEM REMOVAL COMPLAINT AND POSSIBLE SOLUTIONS FOR A SUCCESSFUL IMPLANT REMOVAL. THE COMPLAINANT REPORTED THAT THE DIFFICULTY REMOVING THE IMPLANT WAS DUE TO BONE GROWTH THAT HAD PENETRATED THE FENESTRATIONS IN THE IMPLANT, RESULTING IN INCREASED RESISTANCE WHEN ATTEMPTING TO REMOVE THE IMPLANT. POSSIBLE SOLUTIONS WERE DISCUSSED TO REMOVE BONY INGROWTH BOTH WITHIN THE IMPLANT AND SURROUNDING THE PROXIMAL END OF THE IMPLANT, WHICH WOULD REDUCE THE FORCE REQUIRED TO REMOVE THE IMPLANT. THE SURGICAL SYSTEM IS INTENDED TO PROMOTE BONE GROWTH AND FUSION. PER THE SYSTEM PRODUCT GUIDE, THE DESIGN OF THE IMPLANT ALLOWS FOR BONE GRAFT TO BE INTRODUCED INTO THE JOINT AND IMPLANT IN ORDER TO PROMOTE FUSION. THE SURGICAL SYSTEM IS A TRUE BONY FUSION AND ARTHRODESIS SYSTEM. THE IMPLANT AND INSTRUMENTATION SUITE ALLOWS FOR DIRECT EXPOSURE AND PREPARATION OF THE SI JOINT SURFACE, PLACEMENT OF BONE GRAFT INTO THE SI JOINT SPACE UNDER DIRECT VISUALIZATION, AND PLACEMENT OF BONE GRAFT DIRECTLY WITH THE SYSTEM IMPLANT ITSELF. THERE HAVE NOT BEEN ANY OTHER COMPLAINTS OF SIMILAR NATURE IN THE PAST 12 MONTHS. THE COMPANY WILL CONTINUE TO MONITOR THIS DEVICE FOR COMPLAINTS FROM THE FIELD. CONTINUOUS ATTEMPTS TO GATHER COMPLAINT INCIDENT INFORMATION HAVE BEEN MADE, AND A FOLLOW-UP REPORT WILL BE SUBMITTED IF/WHEN THERE IS ADDITIONAL INFORMATION AVAILABLE REGARDING THE SCHEDULED REVISION PROCEDURE AND PATIENT HEALTH STATUS. THIS REPORT IS ASSOCIATED WITH 3005031160-2021-00013.

    Description of Event or Problem · 1

    THE COMPANY RECEIVED NOTIFICATION ON 6/28/2021 OF AN IMPLANT REMOVAL INSTRUMENT MALFUNCTION THAT OCCURRED DURING A SCHEDULED REMOVAL/REVISION PROCEDURE. THE REVISION PROCEDURE WAS BEING PERFORMED DUE TO INSUFFICIENT IMPLANT PLACEMENT DURING THE ORIGINAL (B)(6) 2020 PROCEDURE. THE SYSTEM IMPLANT WAS PRESSING ON THE PATIENT'S S1 NERVE ROOT, PRESENTING PAIN AND PARTIAL NERVE LOSS. THE REMOVAL PROCEDURE WAS UNSUCCESSFUL, APPROXIMATELY 30-MINUTES WAS SPENT RECOVERING THE BROKEN INSTRUMENT COMPONENTS. A RETURN AUTHORIZATION LABEL WAS ISSUED FOR RETURN OF THE SURGICAL TRAY THAT CONTAINED THE COMPLAINT INSTRUMENT, WHICH ARRIVED AT THE COMPANY FOR COMPLAINT ASSESSMENT ON 6/25/2021.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1139866 SILEX SACROILIAC JOINT FUSION SYSTEM SACROILIAC JOINT FIXATION/SACROILIAC JOINT FUSION OUR XTANT MEDICAL

    Patients

    Seq Age Sex Outcome Treatment
    1 54 YR Other